GENE ONLINE|News &
Opinion
Blog

Gene Therapy
Ajinomoto to Acquire Forge Biologics for $620 Million to Boost Gene Therapy Capabilities
2023-11-14
GeneOnline’s Weekly News Highlights: June 26-30
2023-07-03
Promising Clinical Data Supports Clinical Initiation of Epic Bio’s FSHD Therapy
2023-06-27
Revolutionizing Eye Disease Treatment with iPSC Therapy
2023-03-07
Global Head of Research of Kite Pharma Unveiled the Key Elements to Success in Adoptive Cell Therapy
2023-03-07
CSL’s Hemgenix Wins First Gene Therapy Approval For Hemophilia In Europe
2023-02-21
Immusoft’s B Cell Gene Therapy Gets FDA Nod to Enter Clinical Trials
2023-02-13
Patent Landscape Analysis of Gene Therapy
2023-02-08
EMA Plans to Issue Liver Failure Warning for Novartis’ Gene Therapy
2023-01-16
Will Breakthrough Therapy Lead the Way? An Overview of the Approved Gene and Cell Therapies for 2022
2023-01-13
Hemgenix Marks Most Expensive Treatment Ever and First Gene Therapy for Hemophilia B
2022-11-22
Astellas Invests $50 Million In Taysha, Licenses Two CNS Gene Therapies
2022-10-25
Eli Lilly Snatches Up Akouos Treating Ear Conditions for $487 million
2022-10-18
FDA Accepts Resubmission of BioMarin’s Gene Therapy Two Years After Rejection
2022-10-13
Pfizer Opts In On Neurological Target In Voyager Deal, Leaving $290 Million In Milestones
2022-10-05
1 2 3 9
LATEST
Absci Accelerates Breakthroughs in AI-Designed Drugs with AstraZeneca and Almirall Collaborations
2023-12-06
Saving Lives Through Communication, Heroic Faith Medical Science Showcasing Novel AI Auscultation Tool for Procedural Sedation Patients in PGA 77
2023-12-05
AbbVie Invests $10.1 Billion in ImmunoGen, Targeting the Ovarian Cancer Landscape
2023-12-05
PRISM BioLab and Eli Lilly Join Forces in Revolutionary Drug Discovery Collaboration
2023-12-05
Novel Hydrogel Delivery System Could Reduce Daily Diabetes Injections to Three Times a Year
2023-12-04
Unveiling the Role of Microbes in Climate Change at COP28
2023-12-04
GeneOnline’s Weekly News Highlights: Nov 20-Nov 24
2023-11-27
EVENT
Scroll to Top